Furthermore, resistin was found to be an independent predictor of the main adverse cardiovascular events, including cardiovascular death, myocardial infarction, and restenosis in patients after transcutaneous transluminal coronary angioplasty [51,52]. The gene discussed is RETN; the disease is myocardial infarction.